Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News and Views
Nature Biotechnology 24, 1233 (1 October 2006) | doi:10.1038/nbt1006-1233
Research Highlights
Abstract
Plants could provide a cost-effective platform for producing protein therapeutics, but so far, researchers have been unable to produce large quantities of complex hetero-oligomeric proteins, like antibodies, in plants. Recent work by Giritch et al.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
